STYLE SHEET
GLOBAL CSS
COLORS
ANIMATIONS
MEDIA QUERY
SPACING SYSTEM

Why only for healthcare professionals?

The content on these information pages is directed solely at you if you are a doctor, nurse, or pharmacist, as it concerns treatment with prescription medicines.

Please confirm that you are a healthcare professional (healthcare assistant, nurse, doctor, psychologist, or other licensed healthcare professional).

Back to main page

Confirm and continue

Yazen transforms the accessibility of obesity treatment: A new era in healthcare

Since the World Health Organization recognized obesity as a chronic disease back in 1997, it has only recently begun to be treated as such. Yazen, a Swedish healthcare service, tackles this challenge with a groundbreaking, accessible, and comprehensive treatment approach.

By focusing on the hormonal imbalance that causes obesity, Yazen offers medical treatments that work in conjunction with lifestyle changes, guided by a team of health experts. With their new treatment philosophy and an innovative digital platform, Yazen paves the way for more preventive care and hope for a healthier future for patients across Sweden – and soon, the world over.

Read full article on Näringsliv.se (page 7)

Start your weight loss journey with Yazen today

Everything you need to do is to create an account and answer some questions about your health

Get Started
Get Started
Get Started

More news

Press release
Yazen expands in Scandinavia through the acquisition of Medstart

Yazen expands in Scandinavia through the acquisition of Danish company Medstart, which is established in Denmark and Norway. Together, they enhance care for people with obesity.

News
Discover Annie's sustainable weight loss journey with Yazen

Busy mum Annie found sustainable weight loss with Yazen. Four months in, she's healthier, confident, and embracing a positive, lasting lifestyle change.

Press release
Yazen Health closes €19.5M series A to drive global growth

Yazen Health has successfully closed an oversubscribed €19.5 million series A funding round to fuel its international expansion. This investment enables Yazen to enhance its pioneering obesity treatment model, combining modern weight loss medication with comprehensive lifestyle support.